Training Course - uni-muenster.de · PET and SPECT radiopharmaceuticals development: radiosynthesis, preclinical evaluation, GMP and clinical dossier December 1-4, 2014 Amsterdam,

PET and SPECT radiopharmaceuticals development: radiosynthesis,

preclinical evaluation, GMP and clinical dossier

December 1-4, 2014Amsterdam, The Netherlands

INMiNDTraining Course

Imaging of Neuroinflammation in Neurodegenerative Diseases

Registration

Fee• INMiND members: 200€• Academic institutions: 400€• Industry: 800€

DeadlineOctober 31, 2014

Number of participantsCourse A: min 6 / max 12Course B: min 4 / max 8

For registration please contact:

INMiND Training OfficeCorinne CARREAUX Phone: +33 1 69 08 25 02 Email: [email protected]

Amsterdam Skyline

Venue

The course will be given at the Radionuclide Center of the department of Radiology and Nuclear Medicine, VU University medical center (www.rnc.vu.nl).

VU University Amsterdam

Cover PhotoRadiopharmaceutical manufacture in a GMP setting. High quality for research.

Training Site

This training site covers a broad spectrum of critical knowledge at a basic level for radiopharmaceutical scientists who want to learn more about radiopharmaceutical development; design of radiopharmaceuticals, radiochemistry of radiopharmaceuticals with focus on fluor-18 and iodine-123, the use of PET in drug development, IMPD and GMP as well as all important aspects of radiopharmaceutical development from conceptual idea to application in humans.

CreditsUp to 2 ECTS points can be given to the course participants by their home university.

Training Objectives

The objective of both courses is to give participants a basic introduction into important aspects of radiopharmaceutical development, TS4a from a regulatory perspective, TS4b from a chemistry and pharmacy perspective. In addition important applications, like PET in drug development are addressed.

Duration4-days (28 hours) teaching packages in small groups

Course A: Regulatory Topics75% lectures, 25% hands-on

• Set up of GMP according to eudralex 4• Design of a regulatory dossier for human

applications• Radiopharmaceutical development and

applications• Make an audit of the VUmc GMP system

Course B: Radiochemistry and Tracer Development

75% lectures, 25% practical work• Design of radiopharmaceuticals• Development of radiopharmaceuticals• Radiochemistry of fluorine-18 and iodine-123• Cyclotron technique• Metabolite analysis

Teachers

Lectures will be given by scientists from• University of Leuven, Belgium• Karolinska Institute, Stockholm, Sweden• VU medical center, Amsterdam, Netherlands• University of Tours, France

Course Leader• Bert WINDHORST

Phone: + 31 2044 49707 Email: [email protected]

Scientific Advisors• Guy BORMANS• Frédéric DOLLÉ• Christer HALLDIN• Johnny VERCOUILLIE• Bert WINDHORST

For further details on the course please visit www.uni-muenster.de/INMiND/training